PureTech Historical Financial Ratios
| PRTC Stock | USD 22.55 0.77 3.54% |
PureTech Health is promptly reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 17.41, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 2.43 will help investors to properly organize and evaluate PureTech Health PLC financial condition quickly.
PureTech |
About PureTech Financial Ratios Analysis
PureTech Health PLCFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate PureTech Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on PureTech financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across PureTech Health history.
PureTech Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing PureTech Health PLC stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on PureTech Health sales, a figure that is much harder to manipulate than other PureTech Health PLC multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is PureTech Health PLC dividend as a percentage of PureTech Health stock price. PureTech Health PLC dividend yield is a measure of PureTech Health stock productivity, which can be interpreted as interest rate earned on an PureTech Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Quick Ratio
A measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities.Most ratios from PureTech Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into PureTech Health PLC current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. At present, PureTech Health's PTB Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 341.14, whereas Price To Sales Ratio is forecasted to decline to 222.13.
| 2023 | 2024 (projected) | Dividend Yield | 1.1E-5 | 2.0E-5 | Price To Sales Ratio | 233.82 | 222.13 |
PureTech Health fundamentals Correlations
Click cells to compare fundamentals
PureTech Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PureTech Health fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 1.3K | 1.9K | 1.1K | 4.3K | 233.82 | 222.13 | |
| Ptb Ratio | 16.85 | 24.13 | 17.87 | 16.46 | 1.68 | 1.76 | |
| Days Sales Outstanding | 97.76 | 128.61 | 131.27 | 2.2K | 260.43 | 341.14 | |
| Book Value Per Share | 2.22 | 2.18 | 2.04 | 1.96 | 16.58 | 17.41 | |
| Free Cash Flow Yield | (0.009831) | (0.008493) | (0.0155) | (0.0203) | (0.14) | (0.13) | |
| Operating Cash Flow Per Share | (0.34) | (0.44) | (0.55) | (0.64) | (3.83) | (3.64) | |
| Stock Based Compensation To Revenue | 0.77 | 1.67 | 1.28 | 7.03 | 1.33 | 2.43 | |
| Capex To Depreciation | 1.88 | 0.82 | 0.78 | 0.24 | 0.0497 | 0.0472 | |
| Pb Ratio | 16.85 | 24.13 | 17.87 | 16.46 | 1.68 | 1.76 | |
| Ev To Sales | 1.3K | 1.9K | 1.0K | 4.2K | 184.05 | 174.85 | |
| Roic | (0.15) | (0.0405) | (0.26) | (0.14) | (0.58) | (0.61) | |
| Net Income Per Share | 1.44 | 0.0153 | (0.22) | (0.13) | (2.38) | (2.26) | |
| Payables Turnover | 16.67 | 7.74 | 9.74 | 5.75 | 0.34 | 0.32 | |
| Sales General And Administrative To Revenue | 4.02 | 3.18 | 3.08 | 17.07 | 7.56 | 8.14 | |
| Research And Ddevelopement To Revenue | 7.5 | 7.34 | 8.17 | 55.56 | 28.9 | 15.6 | |
| Capex To Revenue | 1.44 | 0.65 | 0.57 | 1.04 | 0.0736 | 0.0699 | |
| Cash Per Share | 0.56 | 1.34 | 1.62 | 1.25 | 11.84 | 12.43 | |
| Pocfratio | (114.71) | (122.59) | (67.0) | (49.91) | (7.35) | (7.72) | |
| Interest Coverage | (51.21) | (40.57) | (31.88) | (50.04) | (10.84) | (11.38) | |
| Capex To Operating Cash Flow | (0.13) | (0.0411) | (0.0358) | (0.0122) | (0.002313) | (0.002429) | |
| Pfcf Ratio | (101.72) | (117.74) | (64.68) | (49.31) | (7.33) | (7.7) | |
| Days Payables Outstanding | 21.9 | 47.19 | 37.48 | 63.46 | 1.1K | 1.1K | |
| Income Quality | (0.27) | (28.86) | 2.52 | 4.82 | 1.61 | 1.69 | |
| Roe | 0.63 | 0.00682 | (0.11) | (0.0684) | (0.14) | (0.13) | |
| Ev To Operating Cash Flow | (113.76) | (120.1) | (64.38) | (49.34) | (5.79) | (6.08) | |
| Pe Ratio | 26.74 | 3.5K | (169.1) | (240.77) | (11.85) | (11.26) | |
| Return On Tangible Assets | (0.0995) | 0.45 | 0.004618 | (0.0664) | (0.0528) | (0.0948) | |
| Ev To Free Cash Flow | (100.88) | (115.36) | (62.16) | (48.74) | (5.77) | (6.06) | |
| Earnings Yield | 0.0374 | 2.83E-4 | (0.005914) | (0.004153) | (0.0844) | (0.0802) | |
| Intangibles To Total Assets | 6.64E-4 | 9.08E-4 | 0.001043 | 0.001183 | 0.001306 | 0.00124 | |
| Net Debt To E B I T D A | (0.2) | (5.22) | 8.81 | 1.97 | 14.25 | 14.97 | |
| Current Ratio | 1.21 | 2.29 | 2.22 | 3.99 | 6.76 | 7.1 | |
| Tangible Book Value Per Share | 2.22 | 2.18 | 2.03 | 1.95 | 16.55 | 17.38 | |
| Receivables Turnover | 3.73 | 2.84 | 2.78 | 0.17 | 1.4 | 1.33 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PureTech Health PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.615 | Earnings Share (3.00) | Revenue Per Share 0.02 | Quarterly Revenue Growth (0.91) | Return On Assets (0.13) |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.